Company Profile
Hyperfine Stock Price, News & Analysis
- Ticker:
- HYPR
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
0.96 USD (+0.69%)
Close
Last updated: July 27, 2026
149M USD
Market cap
Why the stock is moving
As of Jul 27, 2026, HYPR closed up 0.69% at $0.9605. No new same-company headline was identified in the current news window.
Company overview
Business overview
Hyperfine is a medical device company focused on portable MRI systems and point-of-care imaging. Its business is centered on making advanced imaging more accessible outside traditional radiology settings.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Hyperfine sits in medical imaging and devices.
Business Model Characteristics
The company depends on device adoption, clinical workflow integration, and the expansion of portable imaging use.
Position Within the Biotechnology Landscape
Hyperfine is a healthcare-technology name whose stock is driven by product adoption and execution.
Future catalysts
For Hyperfine, the near-term story still runs through FDA-cleared and AI-powered. Recent commentary puts the focus on continued work around FDA-cleared and AI-powered and the next company-specific development update. That leaves the stock tied to whether the next milestone lands on schedule.
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Denali Therapeutics to Report Second Quarter 2026 Financial Results and Business Highlights on August 6, 2026
DNLI · Source: Denali Therapeutics
- 02
- 03
ICU Medical Announces Time of Second Quarter 2026 Earnings Conference Call
ICUI · Source: ICU Medical
- 04
Encompass Health increases and declares dividend on common stock
EHC · Source: Encompass Health Corporation
- 05
ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026
CLPT · Source: ClearPoint Neuro
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Hyperfine (HYPR)?
Hyperfine (HYPR) most recently closed at 0.96 USD, a +0.69% move versus the previous session.
What is the market cap of Hyperfine (HYPR)?
Hyperfine currently has a market capitalization of 149M USD on BioPharmSignal.
What does Hyperfine do?
Hyperfine is a medical device company focused on portable MRI systems and point-of-care imaging. Its business is centered on making advanced imaging more accessible outside traditional radiology settings.
On which exchange is HYPR stock listed?
Hyperfine (HYPR) is associated with NASDAQ, United States, Biopharma.
What is Hyperfine?
For Hyperfine, the near-term story still runs through FDA-cleared and AI-powered.
Which conditions is Hyperfine targeting with Hyperfine?
For Hyperfine, the near-term story still runs through FDA-cleared and AI-powered.
How does Hyperfine describe recent progress with Hyperfine?
For Hyperfine, the near-term story still runs through FDA-cleared and AI-powered.
What is FDA-cleared?
For Hyperfine, the near-term story still runs through FDA-cleared and AI-powered.